User profiles for Jinxiu Li
 | Jinxiu LiUniversity of Utah Verified email at hci.utah.edu Cited by 525 |
Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019
…, X Liao, Y Su, X Wang, J Yuan, T Li, J Li… - Clinical infectious …, 2020 - academic.oup.com
Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody
response in infected patients remains largely unknown, and the clinical value of antibody …
response in infected patients remains largely unknown, and the clinical value of antibody …
Treatment of 5 critically ill patients with COVID-19 with convalescent plasma
…, Z Wang, F Zhao, Y Yang, J Li, J Yuan, F Wang, D Li… - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic
agents and substantial mortality. It is critical to find new treatments. Objective To determine …
agents and substantial mortality. It is critical to find new treatments. Objective To determine …
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
…, F Huang, F Wang, J Yuan, Z Wang, J Li, J Li… - Science China Life …, 2020 - Springer
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province,
and rapidly spread to many provinces in China as well as other countries. Here we report …
and rapidly spread to many provinces in China as well as other countries. Here we report …
A role for SMARCB1 in synovial sarcomagenesis reveals that SS18–SSX induces canonical BAF destruction
J Li, TS Mulvihill, L Li, JJ Barrott, ML Nelson, L Wagner… - Cancer discovery, 2021 - AACR
The protein level of BAF component SMARCB1 is reduced in synovial sarcoma but plays a
defining role, incorporating into PBAF and SS18–SSX-containing canonical BAF complexes. …
defining role, incorporating into PBAF and SS18–SSX-containing canonical BAF complexes. …
The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing
…, Y Liu, J Yuan, Y Wen, G Xu, J Zhao, L Chen, J Li… - MedRxiv, 2020 - medrxiv.org
The novel coronavirus SARS-CoV-2, etiological agent of recently named Coronavirus infected
disease (COVID-19) by WHO, has caused more than 2, 000 deaths worldwide since its …
disease (COVID-19) by WHO, has caused more than 2, 000 deaths worldwide since its …
[HTML][HTML] Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
…, Y Liu, J Yuan, Y Wen, G Xu, J Zhao, L Cheng, J Li… - Nature medicine, 2020 - nature.com
Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19)
severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells …
severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells …
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
…, J Li, J Yuan, J Wei, F Huang, F Wang, G Li, Y Li… - Journal of Allergy and …, 2020 - Elsevier
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections
Y Yang, M Yang, C Shen, F Wang, J Yuan, J Li… - MedRxiv, 2020 - medrxiv.org
Background The outbreak of novel coronavirus pneumonia (NCP) caused by 2019-nCoV
spread rapidly, and elucidating the diagnostic accuracy of different respiratory specimens is …
spread rapidly, and elucidating the diagnostic accuracy of different respiratory specimens is …
[PDF][PDF] Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury
…, X Li, D Zhao, S Li, S Tan, Z Wang, J Li… - National Science …, 2020 - academic.oup.com
A recent outbreak of pneumonia in Wuhan, China was found to be caused by a 2019 novel
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …
Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)
W Luo, H Yu, J Gou, X Li, Y Sun, J Li, L Liu - 2020 - preprints.org
Aim: Novel coronavirus pneumonia (COVID-19) have emerged as major global health
threats since December, 2019. Up to now, the histopathology of critical patient with COVID-19 …
threats since December, 2019. Up to now, the histopathology of critical patient with COVID-19 …